Citation Impact
Citing Papers
Update: Ambulatory Blood Pressure Monitoring in Children and Adolescents
2014
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
2020 StandoutScience
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Twenty-Four–Hour Ambulatory BP in Snoring Children With Obstructive Sleep Apnea Syndrome
2006
Hypersensitivity from Intravenous Iron Products
2014
Should mean arterial pressure be included in the definition of ambulatory hypertension in children?
2013
Ambulatory Blood Pressure and Increased Left Ventricular Mass in Children at Risk for Hypertension
2007
Receptor-specific Ubiquitination of β-Arrestin Directs Assembly and Targeting of Seven-transmembrane Receptor Signalosomes
2005 StandoutNobel
Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients
2000
The emerging role of ACE2 in physiology and disease
2007
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Demographics of blood pressure and hypertension in children on renal replacement therapy in Europe
2011
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Diabetic renal disease: from recent studies to improved clinical practice
2004
pp60v- Induction of Cyclin D1 Requires Collaborative Interactions between the Extracellular Signal-regulated Kinase, p38, and Jun Kinase Pathways
1999
Mortality risk among hemodialysis patients receiving different vitamin D analogs
2006
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
White-coat and masked hypertension in children: association with target-organ damage
2005
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
2001 Standout
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
2008 Standout
The metabolic syndrome
2010 Standout
The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats
2007
Predominance of nocturnal hypertension in pediatric renal allograft recipients*
2006
β-Arrestin 1 and Gαq/11 Coordinately Activate RhoA and Stress Fiber Formation following Receptor Stimulation
2004 StandoutNobel
The Association of Pediatric Obesity With Nocturnal Non-Dipping on 24-Hour Ambulatory Blood Pressure Monitoring
2015
Impact of Ergocalciferol Treatment of Vitamin D Deficiency on Serum Parathyroid Hormone Concentrations in Chronic Kidney Disease
2007
Stat3 as an Oncogene
1999 Standout
Vitamin D Deficiency
2007 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Long-Term Control of Ambulatory Hypertension in Children: Improving With Time But Still Not Achieving New Blood Pressure Goals
2013
Cinacalcet HCl and Concurrent Low-dose Vitamin D Improves Treatment of Secondary Hyperparathyroidism in Dialysis Patients Compared with Vitamin D Alone
2008
The impact of the degree of obesity on the discrepancies between office and ambulatory blood pressure values in youth
2006
Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
2013
Hypertension in Pediatric Long-term Hemodialysis Patients in the United States
2009
The Hallmarks of Cancer
2000 Standout
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
2007
Poor Glycemic Control is Associated with Abnormal Changes in 24-hour Ambulatory Blood Pressure in Children and Adolescents with Type 1 Diabetes Mellitus
2009
Collectrin, a Collecting Duct-specific Transmembrane Glycoprotein, Is a Novel Homolog of ACE2 and Is Developmentally Regulated in Embryonic Kidneys
2001
Paricalcitol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy
2006
ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular Injury
2001 StandoutNobel
VITAMIN D IN HEALTH AND DISEASE: Vitamin D for Health and in Chronic Kidney Disease
2005
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy
2003
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis
2008
The Effect of Combined Calcium and Vitamin D3 Supplementation on Serum Intact Parathyroid Hormone in Moderate CKD
2009
An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
2020
The metabolic syndrome
2005 Standout
Impact of Activated Vitamin D and Race on Survival among Hemodialysis Patients
2008
The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.
1997 StandoutNobel
Human blood vessel organoids as a model of diabetic vasculopathy
2019 Nature
PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Renal Osteodystrophy, Phosphate Homeostasis, and Vascular Calcification
2007
Transcriptional Regulation of Rat Cyclin D1 Gene by CpG Methylation Status in Promoter Region
1999
A Membrane-proximal Basic Domain and Cysteine Cluster in the C-terminal Tail of CCR5 Constitute a Bipartite Motif Critical for Cell Surface Expression
2001 StandoutNobel
Drugs acting on renin angiotensin system and use in ill patients with COVID-19
2020
The Aquaporins, Blueprints for Cellular Plumbing Systems
1998 StandoutNobel
Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series
2020 Standout
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
2006
Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis
2005
Alterations of blood pressure in type 1 diabetic children and adolescents
2006
The molecular basis of nephrogenic diabetes insipidus
1998
Activated Injectable Vitamin D and Hemodialysis Survival
2005
Angiotensin II-induced Transcriptional Activation of the Cyclin D1 Gene Is Mediated by Egr-1 in CHO-AT1A Cells
2001
Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling
2020
Predictors of Blood Pressure and Its Control in Pediatric Patients Receiving Dialysis
2011
Role of Hyperphosphatemia and 1,25-Dihydroxyvitamin D in Vascular Calcification and Mortality in Fibroblastic Growth Factor 23 Null Mice
2007
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
2020 StandoutNature
Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla.
1995
Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells
1999
Reduced Cell Surface Expression of CCR5 in CCR5Δ32 Heterozygotes Is Mediated by Gene Dosage, Rather Than by Receptor Sequestration
2002 StandoutNobel
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
2008
The Hallmarks of Aging
2013 Standout
Stable Interaction between β-Arrestin 2 and Angiotensin Type 1A Receptor Is Required for β-Arrestin 2-mediated Activation of Extracellular Signal-regulated Kinases 1 and 2
2004 StandoutNobel
The effect of RAAS blockade on the progression of diabetic nephropathy
2013
Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19
2021
Intravenous Paricalcitol for Treatment of Secondary Hyperparathyroidism in Children on Hemodialysis
2007
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Microalbuminuria and Abnormal Ambulatory Blood Pressure in Adolescents With Type 2 Diabetes Mellitus
2005
Human DNA methylomes at base resolution show widespread epigenomic differences
2009 StandoutNature
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
2020 Standout
Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker
2014
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
ACE2: A New Target for Cardiovascular Disease Therapeutics
2007
Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage—foam cell accumulation independently of blood pressure and plasma lipids
1994
Stabilizing the closed SARS-CoV-2 spike trimer
2021
Hypertension in patients with cushing’s disease: Pathophysiology, diagnosis, and management
2005
Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl
2005
Anemia of Chronic Disease
2005 Standout
PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Phosphate Metabolism in the Setting of Chronic Kidney Disease: Significance and Recommendations for Treatment
2007
Blood pressure abnormalities in children with sickle cell anemia
2013
Digoxin inhibits development of hypoxic pulmonary hypertension in mice
2012 StandoutNobel
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
The human AQP4 gene: definition of the locus encoding two water channel polypeptides in brain.
1996 StandoutNobel
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Regulation of the Escherichia coli water channel gene aqpZ
1998 StandoutNobel
Meta-analysis: Vitamin D Compounds in Chronic Kidney Disease
2007
Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium.
1993
Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2
2003 StandoutNobel
Intravenous Iron Optimizes the Response to Recombinant Human Erythropoietin in Cancer Patients With Chemotherapy-Related Anemia: A Multicenter, Open-Label, Randomized Trial
2004
Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells
2000
Angiotensin-Converting Enzyme 2: The First Decade
2011
The Science Underlying COVID-19
2020
Angiotensin-Converting Enzyme II in the Heart and the Kidney
2006
Role of Vitamin D Deficiency in Chronic Kidney Disease
2007
Angiotensin II Activates Mitogen-Activated Protein Kinase Via Protein Kinase C and Ras/Raf-1 Kinase in Bovine Adrenal Glomerulosa Cells
1998
Added Impact of Obesity and Insulin Resistance in Nocturnal Blood Pressure Elevation in Children and Adolescents
2008
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
2020
Posttransplant Acidosis and Associated Disorders of Mineral Metabolism in Patients With a Renal Graft
2007
Arterial Hypertension Determined by Ambulatory Blood Pressure Profiles
2008
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
2020 Standout
Integrin Signaling
1999 StandoutScience
Aquaporin-1 water channel protein in lung: ontogeny, steroid-induced expression, and distribution in rat.
1996 StandoutNobel
Effect of a converting-enzyme inhibitor on vasa recta blood flow in rat kidney
1988
Is Daytime Systolic Load an Important Risk Factor for Target Organ Damage in Pediatric Hypertension?
2015
The Aquaporin Family of Water Channel Proteins in Clinical Medicine
1997 StandoutNobel
Iron-Deficiency Anemia
2015 Standout
ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension
2015
Altered expression of renal AQPs and Na+transporters in rats with Lithium-induced NDI
2000
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
Chronic hypoxia elevates intracellular pH and activates Na+/H+exchange in pulmonary arterial smooth muscle cells
2005
Pathophysiology of the Aquaporin Water Channels
1996 StandoutNobel
Specialized Membrane Domains for Water Transport in Glial Cells: High-Resolution Immunogold Cytochemistry of Aquaporin-4 in Rat Brain
1997 StandoutNobel
Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety
2010
Sodium/Calcium Exchange: Its Physiological Implications
1999 Standout
Circadian variability of blood pressure in obese children
2007
Aquaporins in the Kidney: From Molecules to Medicine
2002 StandoutNobel
Disparate Estimates of Hypertension Control From Ambulatory and Clinic Blood Pressure Measurements in Hypertensive Kidney Disease
2008
Signal Transduction and Signal Modulation by Cell Adhesion Receptors: The Role of Integrins, Cadherins, Immunoglobulin-Cell Adhesion Molecules, and Selectins
1998
Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord
1998 StandoutNobel
Works of Daniel Batlle being referenced
Angiotensin II Activation of Cyclin D1-dependent Kinase Activity
1996
Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan
2008
Sodium‐Calcium Exchange in Bovine Aortic Endothelial Cells
1991
Representational difference analysis of cDNA of genes expressed in embryonic kidney
1997
Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice
2012
Antiproteinuric effect of oral paricalcitol in chronic kidney disease
2005
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism
2003
A Comparison of Dosing Regimens of Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in CKD Stages 3 and 4
2006
Predominance of AT1 Blockade Over Mas–Mediated Angiotensin-(1–7) Mechanisms in the Regulation of Blood Pressure and Renin–Angiotensin System in mRen2.Lewis Rats
2013
Suppression of parathyroid hormone secretion in hemodialysis patients: Comparison of paricalcitol with calcitriol
2001
Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activation
2018
Glomerular Localization and Expression of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting Enzyme
2006
Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients
2003
Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in Stages 3 and 4 CKD
2006
Increase in Nocturnal Blood Pressure and Progression to Microalbuminuria in Type 1 Diabetes
2002
Pharmacologic modulation of ACE2 expression
2008
Free Cytosolic Calcium Regulation via Na+ ‐ Ca2+ Exchange in Cultured Vascular Smooth Muscle Cellsa
1991
ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice
2007
Prevalence, Pathogenesis, and Treatment of Renal Dysfunction Associated With Chronic Lithium Therapy
1987
Renin-Angiotensin System Blockers and the COVID-19 Pandemic
2020
Improvement of Lipid Abnormalities Associated with Proteinuria Using Fosinopril, an Angiotensin-Converting Enzyme Inhibitor
1993
Altered blood pressure during sleep in normotensive subjects with type I diabetes.
1993
Renal Effects of Antihypertensive Drugs
1989
Angiotensin II and Angiotensin-(1-7) Effects on Free Cytosolic Sodium, Intracellular pH, and the Na + -H + Antiporter in Vascular Smooth Muscle
1996
Distal nephron function in patients receiving chronic lithium therapy
1982
Angiotensin II Increases H + -ATPase B1 Subunit Expression in Medullary Collecting Ducts
2005
New Experimental Models of Diabetic Nephropathy in Mice Models of Type 2 Diabetes: Efforts to Replicate Human Nephropathy
2012
Increased ACE 2 and Decreased ACE Protein in Renal Tubules From Diabetic Mice
2004
Na+/H+ exchange and vascular smooth muscle proliferation.
1994
Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States
2003
Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology
2020
Regulation of intracellular pH in the spontaneously hypertensive rat. Role of bicarbonate-dependent transporters.
1994
Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2
2009
Regulation of urinary ACE2 in diabetic mice
2013
ACE and ACE2 Activity in Diabetic Mice
2006
Apelin and ACE2 in cardiovascular disease.
2010
The pathogenesis of hyperchloremic metabolic acidosis associated with kidney transplantation
1981